← Back to all articles

Articles · Earnings, Guidance Tracker

GE HealthCare Technologies (GEHC) Q3 2026 Earnings: Guidance Raised

Q3 2026 (ended Sep 30, 2026): revenue, EPS and full-year guidance from the SEC filing

Published Nov 5, 2026

TL;DR

  • GE HealthCare Technologies raised its full-year guidance; revenue +7.2% vs a year earlier.

GE HealthCare Technologies's results for Q3 2026 (ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-28. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.

At a glance

ItemValue
Revenue (GAAP)$5,513 million (+7.2% vs a year earlier)
Diluted EPS (GAAP)$1.36
Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs)$1.34
Full-year guidanceRaised

Guidance

Raised 2026 adjusted EPS to $4.95–$5.05 (from $4.80–$5.00), organic revenue growth to ~4.0%, free cash flow to $1.6B+; tax rate reaffirmed.

Why this label: 'the Company raises guidance as follows': adjusted EPS $4.95-5.05 vs previous $4.80-5.00, organic growth ~4.0%; tax rate reaffirmed; nothing core lower.

MetricPeriodNewPrior (as stated in the release)
adjusted EPSFY2026$4.95–$5.05$4.80–$5.00
organic revenue growthFY2026~4.0%3.0%–4.0%
adjusted EBIT marginFY202615.5%–15.7%15.4%–15.7%
adjusted effective tax rateFY202620.0%–21.0%20.0%–21.0%
free cash flowFY2026$1.6B+~$1.6B

From the release

Revenue: "Revenues of $5.5 billion, up 7.2%, including Organic revenue growth* of 6.2%, with growth across all segments."

Earnings per share: "Diluted EPS of $1.36 versus $0.98, up $0.38; Adjusted EPS* of $1.34 versus $1.07, up $0.27"

adjusted EPS: "Adjusted EPS* · $4.59 · $4.80 - $5.00 4.6% - 9.0% · $4.95 - $5.05"

organic revenue growth: "Organic Revenue Growth* (1) · 3.5% · 3.0% - 4.0% · ~4.0%"

adjusted EBIT margin: "Adjusted EBIT Margin* · 15.3% · 15.4% - 15.7% 10 - 40 bps · 15.5% - 15.7%"

Quotes are copied from the filing; in table rows, cell borders are shown as “·”.

Key fact: Raised 2026 adjusted EPS guidance to $4.95–$5.05; Q3 diluted EPS up 39.1%.

Source

GE HealthCare Technologies earnings release (SEC filing), accession 0001932393-26-000058, filed 2026-10-28.

Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.

Get the Sunday Recap by email

One email a week. Every issue is published on the site too, so this is only about getting it in your inbox.

Subscribing signs you up for the free YieldTerminal Sunday recap, one email a week. Educational only, not financial advice. Unsubscribe any time.

Educational commentary, not a recommendation to buy or sell anything.